X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/delix-therapeutics-announces-completion-of-1st-cohort-dosing-dose-escalation-approval-in-phase-i-trial-for-novel-compound-dlx-001-301853647.html
https://www.prnewswire.com/news-releases/delix-therapeutics-appoints-aaron-koenig-md-as-chief-medical-officer-301846490.html
https://www.prnewswire.com/news-releases/delix-therapeutics-initiates-phase-i-trial-for-novel-compound-dlx-001-301817260.html
https://www.prnewswire.com/news-releases/delix-therapeutics-partners-with-cellectricon-expressive-neuroscience-and-expands-science-team-to-accelerate-drug-discovery-and-translatability-301745288.html
https://www.prnewswire.com/news-releases/delix-therapeutics-expands-world-class-team-with-first-head-of-rd-301630529.html
https://www.biospace.com/article/releases/delix-therapeutics-partners-with-the-national-institute-on-drug-abuse-nida-to-advance-research-on-non-hallucinogenic-therapies-to-treat-substance-use-disorders/?s=71
https://www.fiercebiotech.com/biotech/delix-raises-70m-to-test-psychedelic-analogs-for-treating-brain-disorders-clinical-trials
https://www.prnewswire.com/news-releases/delix-therapeutics-expands-executive-leadership-team-301325292.html
Market Place
Share 
